EZH2 and hepatocellular carcinoma: In HCC, IL-1R1 knockout reduced tumor growth, steatosis, insulin resistance, and immune cell infiltration.21, 22, 23 In lung cancer, IL-1β downregulated miR-101, leading to EZH2 upregulation, while miR-101 overexpression suppressed tumor growth.